Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets

References

• Modi S, Xiang TX, Anderson BD. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions. J Control Release 2012;162:330–9
   PubMed Web of Science ®Google Scholar
• Ali MH, Moghaddam B, Kirby DJ, et al. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. Int J Pharm 2013;453:225–32
   PubMed Web of Science ®Google Scholar
• Lee JS, Feijen J. Biodegradable polymersomes as carriers and release systems for paclitaxel using Oregon Green(R) 488 labeled paclitaxel as a model compound. J Control Release 2012;158:312–18
   PubMed Web of Science ®Google Scholar
• Caon T, Porto LC, Granada A, et al. Chitosan-decorated polystyrene-b-poly(acrylic acid) polymersomes as novel carriers for topical delivery of finasteride. Eur J Pharm Sci 2014;52:165–72
   PubMed Web of Science ®Google Scholar
• Burapapadh K, Takeuchi H, Sriamornsak P. Novel pectin-based nanoparticles prepared from nanoemulsion templates for improving in vitro dissolution and in vivo absorption of poorly water-soluble drug. Eur J Pharm Biopharm 2012;82:250–61
   PubMed Web of Science ®Google Scholar
• Wang XQ, Zhang Q. pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs. Eur J Pharm Biopharm 2012;82:219–29
   PubMed Web of Science ®Google Scholar
• Mellaerts R, Mols R, Jammaer JA, et al. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur J Pharm Biopharm 2008;69:223–30
   PubMed Web of Science ®Google Scholar
• Vialpando M, Backhuijs F, Martens JA, Van den Mooter G. Risk assessment of premature drug release during wet granulation of ordered mesoporous silica loaded with poorly soluble compounds itraconazole, fenofibrate, naproxen, and ibuprofen. Eur J Pharm Biopharm 2012;81:190–8
   PubMed Web of Science ®Google Scholar
• Jia L, Shen J, Li Z, et al. Successfully tailoring the pore size of mesoporous silica nanoparticles: exploitation of delivery systems for poorly water-soluble drugs. Int J Pharm 2012;439:81–91
   PubMed Web of Science ®Google Scholar
• Kumar D, Sailaja Chirravuri SV, Shastri NR. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Int J Pharm 2014;461:459–68
   PubMed Web of Science ®Google Scholar
• Van Speybroeck M, Mols R, Mellaerts R, et al. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur J Pharm Biopharm 2010;75:354–65
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhi Z, Jiang T, et al. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J Control Release 2010;145:257–63
   PubMed Web of Science ®Google Scholar
• Zhu W, Zhao Q, Sun C, et al. Mesoporous carbon with spherical pores as a carrier for celecoxib with needle-like crystallinity: improve dissolution rate and bioavailability. Mater Sci Eng C 2014;39:13–20
   PubMed Web of Science ®Google Scholar
• Hu Y, Zheng X, Wang J, et al. 3-D macroporous silica and 2-D mesoporous silica as carriers for improved delivery of poorly water-soluble drugs: a comparative study. J Control Release 2013;172:e81
   Google Scholar
• Wang Y, Sun L, Jiang T, et al. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol. Drug Dev Ind Pharm 2014;40:819–28
   PubMed Web of Science ®Google Scholar
• Hu Y, Zhi Z, Wang T, et al. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy. Eur J Pharm Biopharm 2011;79:544–51
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhi Z, Li X, et al. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol. Int J Pharm 2013;454:403–11
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang L, Sun C, et al. Uniform mesoporous carbon as a carrier for poorly water soluble drug and its cytotoxicity study. Eur J Pharm Biopharm 2012;80:535–43
   PubMed Web of Science ®Google Scholar
• Jiang H, Wang T, Wang L, et al. Development of an amorphous mesoporous TiO2 nanosphere as a novel carrier for poorly water-soluble drugs: effect of different crystal forms of TiO2 carriers on drug loading and release behaviors. Microporous Mesoporous Mater 2012;153:124–30
   Web of Science ®Google Scholar
• Xu W, Riikonen J, Lehto V-P. Mesoporous systems for poorly soluble drugs. Int J Pharm 2013;453:181–97
   PubMed Web of Science ®Google Scholar
• Hu Y, Wang J, Zhi Z, et al. Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug. J Colloid Interface Sci 2011;363:410–17
   PubMed Web of Science ®Google Scholar
• Zhang ZH, Dong HY, Peng B, et al. Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs. Int J Pharm 2011;410:41–7
   PubMed Web of Science ®Google Scholar
• Shokri J, Ahmadi P, Rashidi P, et al. Swellable elementary osmotic pump (SEOP): an effective device for delivery of poorly water-soluble drugs. Eur J Pharm Biopharm 2008;68:289–97
   PubMed Web of Science ®Google Scholar
• Xu H, Li Z, Pan H, et al. A novel bi-layer ascending release osmotic pump tablet: in vitro investigation and in vivo investigation in pharmacokinetic study and IVIVC evaluation. Int J Pharm 2013;458:181–7
   PubMed Web of Science ®Google Scholar
• Waterman KC, Goeken GS, Konagurthu S, et al. Osmotic capsules: a universal oral, controlled-release drug delivery dosage form. J Control Release 2011;152:264–9
   PubMed Web of Science ®Google Scholar
• Okimoto K, Tokunaga Y, Ibuki R, et al. Applicability of (SBE)7m-beta-CD in controlled-porosity osmotic pump tablets (OPTs). Int J Pharm 2004;286:81–8
   PubMed Web of Science ®Google Scholar
• Liu X, Wang S, Chai L, et al. A two-step strategy to design high bioavailable controlled-release nimodipine tablets: the push-pull osmotic pump in combination with the micronization/solid dispersion techniques. Int J Pharm 2014;461:529–39
   PubMed Web of Science ®Google Scholar
• Hill A, Geissler S, Weigandt M, Mader K. Controlled delivery of nanosuspensions from osmotic pumps: zero order and non-zero order kinetics. J Control Release 2012;158:403–12
   PubMed Web of Science ®Google Scholar
• Hill A, Breyer S, Geissler S, et al. How do in-vitro release profiles of nanosuspensions from Alzet(R) pumps correspond to the in-vivo situation? A case study on radiolabeled fenofibrate. J Control Release 2013;168:77–87
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang L, Qu X, et al. In vitro and in vivo evaluations of a novel pulsed and controlled osmotic pump capsule. Drug Dev Ind Pharm 2015;41:322–32
   PubMed Web of Science ®Google Scholar
• Tang X, Tai L-Y, Yang X-G, et al. In vitro and in vivo evaluation of gliclazide push–pull osmotic pump coated with aqueous colloidal polymer dispersions. Drug Dev Ind Pharm 2013;39:67–76
   PubMed Web of Science ®Google Scholar
• Ma L, Deng L, Chen J. Applications of poly(ethylene oxide) in controlled release tablet systems: a review. Drug Dev Ind Pharm 2014;40:845–51
   PubMed Web of Science ®Google Scholar
• Nandiyanto ABD, Kim SG, Iskandar F, Okuyama K. Synthesis of spherical mesoporous silica nanoparticles with nanometer-size controllable pores and outer diameters. Microporous Mesoporous Mater 2009;120:447–53
   Web of Science ®Google Scholar
• Niu D, Ma Z, Li Y, Shi J. Synthesis of core-shell structured dual-mesoporous silica spheres with tunable pore size and controllable shell thickness. J Am Chem Soc 2010;132:15144–7
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Nagira S, Yamamoto H, Kawashima Y. Solid dispersion particles of amorphous indomethacin with fine porous silica particles by using spray-drying method. Int J Pharm 2005;293:155–64
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang J, Jiang T, Wang S. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: drug loading and release properties. Int J Pharm 2011;410:118–24
   PubMed Web of Science ®Google Scholar
• Niu X, Wan L, Hou Z, et al. Mesoporous carbon as a novel drug carrier of fenofibrate for enhancement of the dissolution and oral bioavailability. Int J Pharm 2013;452:382–9
   PubMed Web of Science ®Google Scholar
• Rouquerol J, Avnir D, Fairbridge CW, et al. Recommendations for the characterization of porous solids. Pure Appl Chem 1994;66:1739–58
   Web of Science ®Google Scholar